Gaps & Opportunities in Women’s Health

For many years there has been a lack of funds to study issues related to women’s health. It is now more critical than ever for innovators, industry, and investors to take actionable steps to prioritize and improve women’s health.

BioInnovation Institute (BII) and Medicon Valley Alliance (MVA) have partnered up to bring together our networks and shed light on the significant unmet needs in women’s health. We are excited to invite you for a half-day seminar with renowned speakers who represent the triple-helix of academia, healthcare, and industry.

We will first tune in on the gender/data gaps with the Hologic Women’s Health Index 2022, which is based on a survey capturing and measuring women’s experience with health and healthcare. We will also hear from renowned researchers with entrepreneurial experience and how the Bill & Melinda Gates Foundation is supporting women’s health. The day will continue to showcase how new and established companies are making their way into the untapped market. To conclude the day, we are excited to have a panel of Danish and Swedish investors discussing how to ensure more investment in women’s health to capture the market potential.

Date: 6th of December, 2022
Time: 8.30 – 13.30
Venue: Medicon Valley Alliance (HubNordic) – Arne Jacobsens Allé 13, DK-2300 Copenhagen (Ørestad) – Meeting room: Auditorium
Registration: Please note we have reached max capacity and closed for further registrations. Instead you are welcome to sign up to be on the waiting list and then we will let you know early December if we get any cancellations:

WAITING LIST

Speakers
Please refer to specific titles in the program.

	Trine Bartholdy is heading up BII’s Innovation Department, in which the BII Women’s Health Initiative is anchored. Trine has +20 years of experience within life science venture capital and the pharmaceutical industry. Furthermore, she has been the CEO of Maternity Foundation, a non-profit organization developing digital health tools for maternal health.
	Anette Steenberg became the CEO of Medicon Valley Alliance in November 2021. She has had an extensive career in the Ministry of Foreign Affairs of Denmark and has also worked with the combination of life science, investment promotion and regional development in Greater Copenhagen as investment director at Copenhagen Capacity.
	Michael Bronsdijk has +25 years of experience from pharmaceutical and medical device/diagnostics organizations before joining Hologic in 2021. As the General Manager of the branches in the Nordics & Benelux, he is responsible for overall strategy and business development with a strong focus on women’s health.
	Aris Papageorghiou is an academic, clinician-scientist, and inventor. One of his major research lines is on the use of Artificial Intelligence (AI) in pregnancy imaging (both in high and low-income settings). This work led him to co-founding the spin-out Intelligent Ultrasound.
	Henriette Svarre Nielsen is a specialist in obstetrics and gynecology and an expert in reproduction and recurrent pregnancy loss. She is close to both research and the patients, and is also an entrepreneur aiming to develop a diagnostic test in the field of pregnancy loss – as part of the BioInnovation Institute BioStudio.
	Mark Barone leads the Bill & Melinda Gates Foundation’s work to discover and develop new contraceptive methods as well as expand the availability of new and existing contraceptives in low- and middle-income countries.
	Kelle Moley joined Ferring in September 2022 after 30 years as a career physician-scientist and obstetrician/gynacologist, working on basic and translational research on reproductive health issues in females throughout their life course. She has also worked in Non-Profit as CSO of March of Dimes and Philanthropy as Deputy Director of Reproductive Health Technologies at The Gates Foundation.
	Anna Linton joined Pharmiva in August 2022 with 20 years of experience from the pharmaceutical sector, most recently as CEO of Unimedic and before that CEO at Grünenthal and Nordic Lead at Recordati. She also held leading commercial positions for Abbott, Wyeth and Pfizer.
	Karin Lykke-Hartmann is a professor at Aarhus University specializing in early reproduction and embryonic development In 2021, she founded the startup Notify Therapeutics, aiming to develop a first-in-class treatment for infertile women who do not benefit from standard hormone therapy.
	Mohaned Shilaih has a background in clinical development and compliance in women’s health, oncology, and neuroscience. He co-founded FimmCyte where the company vision is to reshape women’s health by developing novel directed non-hormonal treatments, starting with endometriosis.
Moderator
	Trine Petersen is passionate about the Danish healthcare system, its ecosystem, and (lack of) data. Improving female health is very close to her heart, and she is co-founder of a cross-sectoral network dedicated to this. Trine is an Economist specializing in health.
Investor panel
	Helen Pettersson focuses on Life Science and is responsible for the entire investment process. Currently, she is the Investment Manager of 8 of Almi Invest South’s portfolio companies and a board member of 6 companies, three of which are biotech companies. Helen also has a PhD in Tumor Immunology and began her career as a translational cancer researcher.
	Jacob Falck Hansen has +15 years pharma experience from Novo Nordisk and holds an MSc in Biochemistry and PhD from the University of Copenhagen. Jacob is partner at Lundbeckfonden BioCapital – an evergreen venture capital fund that invests in life science companies. The investments covers all therapeutic areas and all stages of development, with a strong focus on early-stage Danish companies.
	Nina Haldipur is a venture investor at Vækstfonden, the Danish state’s investment fund. She leads equity investments in Danish life science companies (specifically pre-seed through Series B) across biotech, medtech, and healthtech, with a keen interest in women’s health.

Organized by
Sponsored by